Jason Haddock

Jason Haddock has more than 20 years of financial and operational experience in the biopharmaceutical industry. Jason served at Array BioPharma, Inc. as Chief Financial Officer where he was instrumental in the execution of an oncology-focused research, development, and commercialization strategy that culminated in the successful launch of two new drugs and the company ultimately being acquired by Pfizer. Prior to Array BioPharm, Jason worked at Bristol-Myers Squibb in a variety of finance, strategic, commercial, and business development capacities including CFO and COO roles for business units in Asia Pacific, Europe and the United States. Jason has also served as CFO for ArcherDX as they united with Invitae to create a global leader in comprehensive cancer genetics and precision oncology. Jason holds a bachelor’s degree in accountancy and an EMBA from Washington University in St. Louis.